Scopus BioPharma Inc (SCPS)
0.0021
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Scopus BioPharma Total Liabilities (Quarterly): 11.00M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 11.00M |
| March 31, 2023 | 9.313M |
| December 31, 2022 | 7.454M |
| September 30, 2022 | 5.920M |
| June 30, 2022 | 5.371M |
| March 31, 2022 | 5.138M |
| December 31, 2021 | 4.170M |
| September 30, 2021 | 2.237M |
| Date | Value |
|---|---|
| June 30, 2021 | 8.792M |
| March 31, 2021 | 4.479M |
| December 31, 2020 | 3.805M |
| September 30, 2020 | 3.789M |
| December 31, 2019 | 0.8545M |
| June 30, 2019 | 0.379M |
| March 31, 2019 | 0.3636M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.379M
Minimum
Jun 2019
11.00M
Maximum
Jun 2023
5.193M
Average
4.809M
Median
Total Liabilities (Quarterly) Benchmarks
| Humanigen Inc | 54.84M |
| Cantabio Pharmaceuticals Inc | 2.215M |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | 69.08M |
| Statera BioPharma Inc | 22.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.4976M |
| Shareholders Equity (Quarterly) | -9.452M |